Discussion In this first systematic review and meta-analysis of monocyte counts and outcomes in patients with ILD, elevated baseline peripheral blood monocytes were associated with higher risk of death and disease progression. However, the higher monocyte count threshold of >0.9×109 cells·L−1 demonstrated greater consistency in its association. These data inform the role of peripheral blood monocyte counts to be used as an important and readily available prognostic biomarker in ILD.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile